To test whether TRAF2 can regulate the stability of EGFR in glioma cells, we performed knockdown of DYRK1A and TRAF2 in human glioma cell lines U251 and A172, and analyzed the protein level of EGFR. This evidence concerns the gene DYRK1A and central nervous system cancer.